Fulcrum Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Fulcrum Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Fulcrum Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Fulcrum Therapeutics Inc. is FULC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Fulcrum Therapeutics Inc. has its primary listing on NASDAQ. You can trade Fulcrum Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Fulcrum Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Fulcrum Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Fulcrum Therapeutics Inc..